↓ Skip to main content

Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases

Overview of attention for book
Cover of 'Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Functional Principles Implied in Neurological Symptoms
  3. Altmetric Badge
    Chapter 2 The Neurobiology of Alzheimer’s Disease
  4. Altmetric Badge
    Chapter 3 Role of Brain Monoamines and Other Neurotransmitters in Normal and Pathological Aging
  5. Altmetric Badge
    Chapter 4 Molecular Genetics of Alzheimer’s Disease
  6. Altmetric Badge
    Chapter 5 Proteins and Proteolysis in the Pathogenesis of Alzheimer’s Disease
  7. Altmetric Badge
    Chapter 6 Amyloid β Protein Precursors having Proteinase Inhibitor Regions are Highly Expressed in Alzheimer’s Disease Brains
  8. Altmetric Badge
    Chapter 7 Differential Expression of Three Types of Amyloid Protein Precursor mRNA in Alzheimer’s Disease Brain
  9. Altmetric Badge
    Chapter 8 Protease Inhibitor and Cholinergic System in Alzheimer’s Disease
  10. Altmetric Badge
    Chapter 9 Structure and Expression of mRNA for the Mouse Homolog of Alzheimer Amyloid Beta Protein Precursor
  11. Altmetric Badge
    Chapter 10 Molecular Cloning and Structural Analysis of the Human Amyloid ß Protein Precursor Gene
  12. Altmetric Badge
    Chapter 11 Protease Nexin 1 Immunoreactivity in Senile Plaques in Alzheimer Disease and Aged Brain
  13. Altmetric Badge
    Chapter 12 Monoclonal Antibodies Against Senile Plaque Amyloid in Alzheimer’s Disease
  14. Altmetric Badge
    Chapter 13 Identification of Putative Amyloid A4-Splitting Enzymes with Two Endopeptidases Widely Distributed in Mammalian Cells
  15. Altmetric Badge
    Chapter 14 Proteolytic Processing of β-Protein Precursor-Related Synthetic Peptides
  16. Altmetric Badge
    Chapter 15 Degeneration of Neuronal Processes in Rats Induced by the Protease Inhibitor Leupeptin
  17. Altmetric Badge
    Chapter 16 α 1-Antichymotrypsin Influences the Survival of Neurons
  18. Altmetric Badge
    Chapter 17 Evidence for a Neuronal Origin of Senile Plaques in Down’s Syndrome Brains
  19. Altmetric Badge
    Chapter 18 Serum Amyloid P Immunoreactivity in Cortical Tangles, Plaques and Vessels in Alzheimer’s Disease: Implications for Dysfunction of the Blood-Brain Barrier?
  20. Altmetric Badge
    Chapter 19 Monoamine Oxidase B Activity in Senile Plaque
  21. Altmetric Badge
    Chapter 20 Light and Electron Microscopic Observations of Diffuse Plaque and Its Related Conditions
  22. Altmetric Badge
    Chapter 21 β-Amyloid Plaques and Dementia: An Immunohistochemical Study
  23. Altmetric Badge
    Chapter 22 Diagnosis of Cerebral Amyloid Angiopathy with Cerebral Hemorrhage by Enzyme-Linked Immunosorbent Assay (ELISA) of Cystatin C in Cerebrospinal Fluid
  24. Altmetric Badge
    Chapter 23 Cystatin C (γ-Trace) and β-Protein Coexist in the Cerebral Amyloid Angiopathy Causing Cerebral Hemorrhage and Consequential Vascular Dementia
  25. Altmetric Badge
    Chapter 24 The Regulation of Cytoskeletal Elements in Differentiating Human Neuroblastoma and Rat Pheochromocytoma PC-12 Cells
  26. Altmetric Badge
    Chapter 25 Some Findings on Intermediate Filaments in Alzheimer’s Disease
  27. Altmetric Badge
    Chapter 26 A Unifying Hypothesis on the Etiology of Alzheimer’s Disease
  28. Altmetric Badge
    Chapter 27 Abnormal Phospholipid Metabolism in Neurodegenerative Diseases: Elevations in Glycerophosphocholine and Glycerophospho-Ethanolamine Levels in Brain of Alzheimer’s Disease But Not in Down Syndrome Patients
  29. Altmetric Badge
    Chapter 28 Alterations in Catecholamine and Peptide Neurons in the Locus Coeruleus in Dementias of Alzheimer’s and Parkinson’s Disease
  30. Altmetric Badge
    Chapter 29 The Role of Neuronal Membranes Deterioration in The Pathogenesis of Alzheimer’s Disease: An Ultrastructural Perspective
  31. Altmetric Badge
    Chapter 30 Experimental Synaptic Degeneration as a Model for the Pathogenesis of Alzheimer’s Disease: Monoclonal Antibodies and a Protein Kinase Inhibitor Block Synapse Formation and Maintenance Between Cultured CNS Neurons
  32. Altmetric Badge
    Chapter 31 Pathobiochemical Aspects of Parkinson’s Disease and Dementia of Alzheimer Type
  33. Altmetric Badge
    Chapter 32 Characterization of Alzheimer Neurofibrillary Tangle (NFT) Epitopes and the Binding Site for the Regulatory Subunit (RII) of cAMP-Dependent Protein Kinase II in Human Microtubule-Associated Protein 2 (MAP-2)
  34. Altmetric Badge
    Chapter 33 Identification and Characterization of Modified Forms of Tau in Brains with Alzheimer’s Disease
  35. Altmetric Badge
    Chapter 34 Phosphorylation of Tau Protein with a Novel Tau Protein Kinase Forming Paired Helical Filament Epitopes on Tau
  36. Altmetric Badge
    Chapter 35 Aberration of Vimentin Array in Fibroblast from Familial Alzheimer’s Disease
  37. Altmetric Badge
    Chapter 36 Regional Phospholipid Profile of Alzheimer’s Brain
  38. Altmetric Badge
    Chapter 37 Age-Related Changes in the Rate and Composition of the Slow Axonal Transport
  39. Altmetric Badge
    Chapter 38 Astroglial Gene Expression in the Hippocampus Following Partial Deafferentation in the Rat and in Alzheimer’s Disease
  40. Altmetric Badge
    Chapter 39 Blood-Brain Barrier Disturbance in Patients with Alzheimer’s Disease is Related to Vascular Factors
  41. Altmetric Badge
    Chapter 40 An Early Change of Neurofibrillary Tangle Formation
  42. Altmetric Badge
    Chapter 41 Monoclonal Antibodies Against Paired Helical Filament in Alzheimer’s Disease and Parkinsonism-Dementia Complex of Guam
  43. Altmetric Badge
    Chapter 42 Patterns of Vulnerability of Mesostriatal Neurons
  44. Altmetric Badge
    Chapter 43 Complex I Deficiency in Parkinson’s Disease and MPTP-Induced Experimental Parkinsonism
  45. Altmetric Badge
    Chapter 44 Biochemical Reactions Leading to Parkinsonian Symptoms Elicited by MPTP
  46. Altmetric Badge
    Chapter 45 Enzymological Aspects of the Actions of the Parkinsonism-Inducing Neurotoxin MPTP
  47. Altmetric Badge
    Chapter 46 Biochemical Studies on Predisposition to Parkinson’s Disease
  48. Altmetric Badge
    Chapter 47 Parkinsoism Produced by an Endogenous Substance, Tetrahydroisoquinoline, in Monkeys and Mice
  49. Altmetric Badge
    Chapter 48 Tetrahydroisoquinoline Alkaloids in Neurodegenerative Disorders - Influence of Drug Treatment
  50. Altmetric Badge
    Chapter 49 Chronic L-Dopa Therapy in Parkinson’s Disease: Can It Accelerate Degeneration of Nigrostriatal Dopaminergic Neurons?
  51. Altmetric Badge
    Chapter 50 Iron-Melanin Interaction in Substantia Nigra as the Neurotoxic Component of Parkinson’s Disease
  52. Altmetric Badge
    Chapter 51 Dopamine Immunocytochemistry in the Nigrostriatal System of Pre- and Postnatal Mice
  53. Altmetric Badge
    Chapter 52 The Effects of N-Metyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration to Maternal Mice on the Catecholamine System in the Brain of Postnatal Mice
  54. Altmetric Badge
    Chapter 53 Mitochondrial Abnormalities in the Nigral Neurons of Crab-Eating Monkeys with Experimental Parkinsonism
  55. Altmetric Badge
    Chapter 54 L-DOPA-Induced Facilitation of Dopamine Release VIA Presynaptic β-Adrenoceptors in Striatal Slices from MPTP-Treated C57BL Mice: Evaluation of the Action of L-DOPA in Animal Model for Parkinsonism
  56. Altmetric Badge
    Chapter 55 Functional Alterations in Striatal Cholinergic and Striato-Nigral Gaba-Ergic Neurons Following 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration
  57. Altmetric Badge
    Chapter 56 Hemiparkinsonism in Monkeys After Unilateral Striatum Infusion of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)
  58. Altmetric Badge
    Chapter 57 Cyclosporin a Enhances Neurotoxicity of N-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) in Mice
  59. Altmetric Badge
    Chapter 58 Effects of Various Drugs on Behavior and Striatal Dopamine Contents in MPTP-Treated Mice Exposed to Stress
  60. Altmetric Badge
    Chapter 59 Acute Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) on Body Temperature of Various Strains of Mice
  61. Altmetric Badge
    Chapter 60 Effect of MPP + and TIQ on Cultured Rat Midbrain Dopaminergic Neurons
  62. Altmetric Badge
    Chapter 61 Assay System for Neurotoxicants Causing Parkinson’s Disease: 1-Methyl-4-Phenylpyridinium Ion (MPP + ) Inhibits Survival of Cultured Neurons from Substantia Nigra of Fetal Monkey( Macaca fascicularis )
  63. Altmetric Badge
    Chapter 62 The Effect of Tetrahydroisoquinoline on the Mitochondrial Respiration
  64. Altmetric Badge
    Chapter 63 Detection of Tetrahydroisoquinoline, a Parkinsonism-Related Compound, in Parkinsonian Brains and Foods by Gas Chromatography-Mass Spectrometry
  65. Altmetric Badge
    Chapter 64 Biosynthesis of N-Methylisoquinolinium Ion, a Potent Inhibitor of Catecholamine Metabolism, from 1,2,3,4-Tetrahydroisoquinoline Through N-Methyl-1,2,3,4-Tetrahydroisoquinoline in Human Brain
  66. Altmetric Badge
    Chapter 65 Importance of 1-Methyltetrahydroisoquinoline (1MeTIQ) in Parkinson’s Disease
  67. Altmetric Badge
    Chapter 66 Formation of a Novel and Neurotoxic Tetrahydroisoquinoline Derivative, 1,3-Dimethyltetrahydroisoquinoline (1, 3DiMeTIQ), a Condensation Product of Amphetamines and Acetaldehyde in Vivo
  68. Altmetric Badge
    Chapter 67 Tryptophan Metabolites in Parkinson’s Brain
  69. Altmetric Badge
    Chapter 68 A Parallel Relationship between Parkinson’s Disease and an Excess of S-Adenosylmethionine-Dependent Biological Methylation in the Brain
  70. Altmetric Badge
    Chapter 69 Dopa and Dopamine Cause the Destruction of Cultured Nerve Cells in the Presence of Iron: Possible Mechanism of the Nigral Degeneration in Parkinson’s Disease
  71. Altmetric Badge
    Chapter 70 Food-Derived Heterocyclic Amines as Potent Inhibitors of Catecholamine Metabolism
  72. Altmetric Badge
    Chapter 71 Senile Changes in the Human Olfactory Bulbs
  73. Altmetric Badge
    Chapter 72 Large Neurons in the Neostriatum and Basal Nucleus of Meynert: Simultaneous Decrease in Alzheimer’s Disease
  74. Altmetric Badge
    Chapter 73 A Comparison of “Pure” Alzheimer’s Disease and Alzheimer’s Disease Plus Vascular Lesions (Mixed Dementia) in the Elderly
  75. Altmetric Badge
    Chapter 74 Choline Acetyltransferase and Substance P Level in Alzheimer’s Disease and Multi-Infarct Dementia
  76. Altmetric Badge
    Chapter 75 A Study on Postmortem Changes in Vasopressin mRNA in Rat Brain Using a Non-Isotopic Method
  77. Altmetric Badge
    Chapter 76 Topographical Distribution, Fine Structure of Component Fibrils, and Immunoreactivity of Neuronal Inclusions in Alzheimer’s, Parkinson’s, and Pick’s Diseases
  78. Altmetric Badge
    Chapter 77 Neuronal Loss in the Substantia Nigra and Ventral Tegmental Area in Parkinson’s Disease and Alzheimer’s Disease
  79. Altmetric Badge
    Chapter 78 Characteristics of Reactive Microglia in Alzheimer’s and Parkinson’s Disease Brain Tissue
  80. Altmetric Badge
    Chapter 79 Alzheimer - Parkinson Disease Spectrum and Diffuse Lewy Body Disease
  81. Altmetric Badge
    Chapter 80 Acetylcholinesterase Histochemical Changes in the Cerebral Cortex of Alzheimer’s Disease
  82. Altmetric Badge
    Chapter 81 Basement Membrane Components in Alzheimer’s Disease
  83. Altmetric Badge
    Chapter 82 Regulation of Cerebral Cortical and Hippocampal Blood Flow by Cholinergic Fibers Originating in the Nucleus Basalis of Meynert and Septal Complex
  84. Altmetric Badge
    Chapter 83 Immune System Reaction to Model Lesions of Rat Brain
  85. Altmetric Badge
    Chapter 84 Computer-Aided Quantitative Analysis of the Distribution of Catecholamine-Containing Fibers in the Primate Prefrontal Cortex
  86. Altmetric Badge
    Chapter 85 Nigrostriatal Loop Disruption in Parkinson’s Disease and Striatonigral Degeneration
  87. Altmetric Badge
    Chapter 86 Immunocytochemical Studies of Substance P and Met-Enkephalin in the Globus Pallidus of Progressive Supranuclear Palsy
  88. Altmetric Badge
    Chapter 87 Heterogeneous Distribution of L-DOPA Immunoreactivity in Dopaminergic Neurons of the Rat Midbrain
  89. Altmetric Badge
    Chapter 88 Cholinergic Systems in Alzheimer’s Disease, Parkinson’s Disease and Progressive Supranuclear Palsy
  90. Altmetric Badge
    Chapter 89 Neurochemical Aspects of Parkinson’s Disease and the Dementing Brain Disorders: Relation to Brain Ageing
  91. Altmetric Badge
    Chapter 90 Neuropharmacology and Functional Anatomy of the Basal Ganglia: Experimental Models for Parkinson’s and Alzheimer’s Disease
  92. Altmetric Badge
    Chapter 91 Neurotransmitter Changes in Alzheimer-Type Dementia and Therapeutic Strategies
  93. Altmetric Badge
    Chapter 92 In Vitro Experimental Approach for Determination of the Central Cholinergic Neuronal Activity
  94. Altmetric Badge
    Chapter 93 Pharmacological Profile of Brain Glucose Utilization Obtained by Monitoring of Lactate Release in Vivo under the Free Moving Condition
  95. Altmetric Badge
    Chapter 94 Behavioral and Neurochemical Evaluation of Stroke-Prone Spontaneously Hypertensive Rats for Vascular Dementia-Animal Model
  96. Altmetric Badge
    Chapter 95 Acetylcholinesterase of Cerebral Microvessels Changes in Alzheimer’s Disease
  97. Altmetric Badge
    Chapter 96 Genes of Human Catecholamine-Synthesizing Enzymes
  98. Altmetric Badge
    Chapter 97 Gene Activity and Neurodegeneration in the Extrapyramidal System: A Progress Report on Molecular and Morphological Correlates
  99. Altmetric Badge
    Chapter 98 Analysis of Dopamine and Neuropeptides in 6-OHDA-Lesioned Rats
  100. Altmetric Badge
    Chapter 99 Enhancement of in Vivo Dopamine Release from the Rat Striatum by 6R-L-Erythro-5,6,7,8-Tetrahydrobiopterin as Studied by Brain Dialysis
  101. Altmetric Badge
    Chapter 100 Preparation of Antigen and Antibody to 3-Methoxy-4-Hydroxyphenyl Glycol(MHPG)
  102. Altmetric Badge
    Chapter 101 Study of Central Putative Neurotransmitters in Rodent Models of Parkinsonism
  103. Altmetric Badge
    Chapter 102 Possible Factors Responsible for Adverse Effects of Long-Term L-Dopa Therapy: Simultaneous Determinations of Dopamine Parameters in Rats
  104. Altmetric Badge
    Chapter 103 Generating and Controlling Multiparameter Data Bases for Biochemical Correlates of Disorders
  105. Altmetric Badge
    Chapter 104 NEUBA ® : A Multicolumn, Multidetector Liquid Chromatograph with Electrochemical Detection for Use in the Identification and Determination of Neurochemicals and Related Species
  106. Altmetric Badge
    Chapter 105 Examination of Central Nervous System Effects of Amphetamine Using NEUBA ®
  107. Altmetric Badge
    Chapter 106 Application of Multi-Dimensional Liquid Chromatography (NEUBA ® ) to the Determination of Neuronal Changes in an Organism
  108. Altmetric Badge
    Chapter 107 Patterns of Tyrosine and Tryptophan Metabolites in Controls and Various Degenerative Disorders
  109. Altmetric Badge
    Chapter 108 Dementia in Parkinson’s Disease and Central Cholinergic Function
  110. Altmetric Badge
    Chapter 109 Subtypes of Nicotinic Receptors in Human Cortex: Selective Changes in Alzheimer Disease
  111. Altmetric Badge
    Chapter 110 Alterations in Muscarinic Cholinergic Receptors and the Second Messenger System in the Cerebral Cortex in Alzheimer-Type Dementia
  112. Altmetric Badge
    Chapter 111 Expression of Nicotinic Acetylcholine Receptor mRNA in the Rat Cerebral Cortex after Lesioning of the Nucleus Basalis Magnocellularis
  113. Altmetric Badge
    Chapter 112 Studies of Central Nervous System Cholinergic Receptors in Alzheimer’s Disease (AD)
  114. Altmetric Badge
    Chapter 113 Cerebellar Excitatory Amino Acid Binding Sites are Differentially Altered in Alzheimer’s Disease
  115. Altmetric Badge
    Chapter 114 Pre- and Postsynaptic Cortical Glutamatergic Binding Sites in Alzheimer’s Disease
  116. Altmetric Badge
    Chapter 115 Reduced N-Methyl-D-Aspartate (NMDA) Receptor-Ion Channel Complex in Alzheimer’s Disease Frontal Cortex
  117. Altmetric Badge
    Chapter 116 The Influence of Priming on the Behavioral Expression of Dopamine Receptor Supersensitivity in Basal Ganglia
  118. Altmetric Badge
    Chapter 117 M1 Receptors Stimulate Dopamine Release Via Protein Kinase C in the Striatum of Freely Moving Rat Studied by Brain Dialysis
  119. Altmetric Badge
    Chapter 118 Effect of MPTP on Dopamine D 2 Receptors in the Aging Mouse Striatum
  120. Altmetric Badge
    Chapter 119 Age-Dependent Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) in the Rat
  121. Altmetric Badge
    Chapter 120 More Rapid Development of Supersensitivity of D-2 Receptors than D-1 Receptors as Examined by Rotational Behavior
  122. Altmetric Badge
    Chapter 121 Features of the Dopaminergic Neurotoxicity of Methamphetamine: A Comparison with MPTP
  123. Altmetric Badge
    Chapter 122 Alteration of [ 3 H] Ins (1,4,5) P 3 and [ 3 H] PDBu Binding Sites in Brains of Patients with Parkinson’s Disease and Multiple System Atrophy
  124. Altmetric Badge
    Chapter 123 The Mechanism of Action of Nerve Growth Factor
  125. Altmetric Badge
    Chapter 124 Nerve Growth Factor Promotes Survival of Cultured Cholinergic Neurons from Nucleus Basalis of Meynert of 2-Week-Old Rats
  126. Altmetric Badge
    Chapter 125 Alterations in Nerve Growth Factor Receptor Containing Neurons in Parkinson’s Disease
  127. Altmetric Badge
    Chapter 126 A Striatal-Derived DA Neuron Growth Factor: Implication in Parkinson’s Disease
  128. Altmetric Badge
    Chapter 127 Co-Localization of Cholinergic and GABAergic Traits in in Vitro Septohippocampal Neurons from Developing Rats
  129. Altmetric Badge
    Chapter 128 A Hippocampal Cell Line Expresses a Membrane-Associated Cholinergic Trophic Activity Not Attributable to Nerve Growth Factor
  130. Altmetric Badge
    Chapter 129 Interleukin-6 as a Neurotrophic Factor for Promoting Survival of Septal Cholinergic Neurons and Mesencephalic Catecholaminergic Neurons from Postnatal Rats
  131. Altmetric Badge
    Chapter 130 Distribution of NGF Receptors in Control and Alzheimer’s Disease Basal Forebrain
  132. Altmetric Badge
    Chapter 131 Trophic Effects of Hippocampus Cell Membrane Fragments on Cultured Medial Septal Cholinergic Neurons
  133. Altmetric Badge
    Chapter 132 Changes in Basal Forebrain Cholinergic Systems Following Excitotoxic Cell Death in the Hippocampus and Cerebral Neocortex
  134. Altmetric Badge
    Chapter 133 Interleukin-3 Promotes Neurite Outgrowth and Elevates Choline Acetyltransferase Activity
  135. Altmetric Badge
    Chapter 134 Memory Impairment in Rats Induced by an Active Fragment of Nerve Growth Factor Antibody
  136. Altmetric Badge
    Chapter 135 Brain’s Calculating Principle
  137. Altmetric Badge
    Chapter 136 Screening for Psychotherapeutic Chemicals by Analysis of Conscious Activity in the Mouse
  138. Altmetric Badge
    Chapter 137 Regulation of Neocortical Electrical Activity by Cholinergic and Noradrenergic Systems
  139. Altmetric Badge
    Chapter 138 Ascending Cholinergic and Monoaminergic Systems in the Brainstem: Do they Constitute a Reticular Activating System?
  140. Altmetric Badge
    Chapter 139 Role of the Medial Limbic System in the Memory Process: A Hypothesis Based on a Radioactive 2-Deoxyglucose Study
  141. Altmetric Badge
    Chapter 140 Effect of Magnetism on Learning Function
  142. Altmetric Badge
    Chapter 141 Morphological Changes of the Brain in Senescence Accelerated Mouse (SAM)-P/8, a Newly Developed Memory-Deficient Strain
  143. Altmetric Badge
    Chapter 142 Age-Related Changes in Blood-Brain Barrier ( BBB )
  144. Altmetric Badge
    Chapter 143 Effect of Aging on NADPH-Diaphorase Neurons in Laterodorsal Tegmental Nucleus and Striatum of Senescence Accelerated Mouse (SAM)
  145. Altmetric Badge
    Chapter 144 Senescence-Accelerated Mouse SAM-P/8 Shows Spontaneous Age-Related Impairment of Ability of Acquisition of Learning and Memory: An Animal Model of Disturbances in Recent Memory with Aging
  146. Altmetric Badge
    Chapter 145 An Experimental Animal Model for the Study of Cholinergic and Serotonergic Neuronal Activity in Aging Brain
  147. Altmetric Badge
    Chapter 146 Aging Effects on Schedule-Control Discrimination Learning Test in Aged Rats as a Model of Alzheimer’s Disease
  148. Altmetric Badge
    Chapter 147 Effect of the Basal Forebrain Lesions on Memory and Learning Performance in Mice
  149. Altmetric Badge
    Chapter 148 Effects of Destruction of Nucleus Basalis Meynert on Operant Study and Neurotransmitters in Rats
  150. Altmetric Badge
    Chapter 149 Characteristic of Learning Deficit Induced by Ibotenic Acid Lesion of the Frontal Cortex Related with the Nucleus Basalis of Meynert in Rats
  151. Altmetric Badge
    Chapter 150 A New Animal Model of Alzheimer’s Disease by Selective Destruction of the Cholinergic Neurons in the Basal Forebrain
  152. Altmetric Badge
    Chapter 151 Impairment of Avoidance Behavior Produced by Destruction of the Cholinergic Projection from the Pedunculopontine Nucleus to the Medial Thalamus
  153. Altmetric Badge
    Chapter 152 Impaired Spatial Learning in Rats with a Trimethyltin-Induced Hippocampal Lesion and the Effect of Fetal Septal Grafting on the Impairment
  154. Altmetric Badge
    Chapter 153 Some Effects of CNS Cholinergic Neurons on Memory and ACh Release
  155. Altmetric Badge
    Chapter 154 Carbon Monoxide (CO)-Induced Delayed Amnesia and Delayed Neuronal Death
  156. Altmetric Badge
    Chapter 155 Modifications in the Levels of Antibodies in the CSF of Parkinson’s Disease Patients Following Adrenal-to-Brain Transplantation
  157. Altmetric Badge
    Chapter 156 Autotransplantation of Parasympathetic Cholinergic Neurons into Alzheimer Model Rat Brain
  158. Altmetric Badge
    Chapter 157 Use of MPTP-Hemiparkinsonian (HP) Monkeys to Evaluate Efficacy of Tissue Implants as a Treatment for Parkinson’s Disease
  159. Altmetric Badge
    Chapter 158 Autotransplantation of Sympathetic Ganglion into the Brain of Parkinsonian Monkey
  160. Altmetric Badge
    Chapter 159 Long-Term Survival of Grafted Cells, Dopamine Synthesis/Release, Receptor Activity, and Functional Recovery after Grafting of Fetal Nigral Cells in Model Animals of Hemi-Parkinson’s Disease
  161. Altmetric Badge
    Chapter 160 Intra-Accumbens Dopaminergic Grafts Restore Methamphetamine-Induced Locomotor Hyperactivity Response and the Release and Metabolism of Dopamine in Rats Having 6-OHDA Lesions in the Ventral Tegmental Area
  162. Altmetric Badge
    Chapter 161 Investigation of MHC Antigens on Neural Graft in Mouse Parkinson’s Models
Attention for Chapter 91: Neurotransmitter Changes in Alzheimer-Type Dementia and Therapeutic Strategies
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Neurotransmitter Changes in Alzheimer-Type Dementia and Therapeutic Strategies
Chapter number 91
Book title
Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases
Published by
Springer, Boston, MA, January 1990
DOI 10.1007/978-1-4684-5844-2_91
Book ISBNs
978-1-4684-5846-6, 978-1-4684-5844-2
Authors

Reiji Iizuka, Heii Arai

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 100%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 100%